ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2830

Epigenetic Cell Counting: A Novel Tool to Quantify Immune Cells in Salivary Glands Detects Robust Correlations of T Follicular Helper Cells with Immunopathology

Joel A.G. van Roon1, Frederique M. Moret1, Sofie L.M. Blokland1, Aike A. Kruize2, Gerben Bouma3, Andre van Maurik3, Sven Olek4, Ulrich Hoffmueller4 and Timothy R.D.J. Radstake5, 1Rheumatology & Clinical Immunology/ Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Immunoinflammation TAU, GlaxoSmithKline, Stevenage, United Kingdom, 4Epiontis GmbH, Berlin, Germany, 5Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: epigenetics and salivary gland, Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Genetics, Genomics and Proteomics

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Histological analysis of salivary glands for decades has been a valuable tool in the characterization of patients with primary Sjögren’s syndrome (pSS) and non-Sjögren’s sicca (nSS) patients. Importantly, it has helped in understanding the immunopathology of sicca patients. Nonetheless, standardization of histological assessments, e.g. to quantify lymphocytic foci or germinal centers is lacking, contributing to improper classification of disease and assessment of risk of lymphoma for example. Also, detailed and reproducible quantification of the heterogeneity of inflammatory cells and their contribution to immunopathology is lacking. Recent progress in epigenetics has revealed that cell-specific DNA methylation profiles can be applied to reliably quantify numbers of cells in blood and tissues. The objective of this study was to investigate whether epigenetic cell counting can serve as a novel reliable tool to quantify immune cells in salivary glands of sicca patients.

Methods: DNA was isolated from frozen tissue sections of 13 nSS, 12 probable SS, 29 pSS and 7 overlap SS patients. Bisulfite conversion of demethylated DNA sites was followed by cell specific qPCR that was used to calculate the percentage of cell subsets related to the total number of cells quantified by housekeeping gene expression. Percentages of epigenetically counted cells were correlated to gene expression generated by RNA-seq analysis of matched salivary gland tissue and histological and clinical parameters (lymphocytic focus score (LFS), %IgA+ plasma cells, serum IgG, SSA positivity).

Results: Strongly increased percentages of epigenetically quantified percentages of CD3, CD4, CD8, B cells, T follicular helper (Tfh) cells and Treg cells in pSS vs nSS patients were observed (all p<0.001, CD8 p<0.05, B cells p<0.01). These inflammatory cell types all strongly correlated with LFS (all at least p<0.001, CD8 p=0.015), local B cell hyperactivity (% IgA+ cells, all p<0.001, except CD8 p=0.060 and B cells p=0.127) and systemic B cell hyperactivity (all at least p<0.01, except CD8 p=0.052). Th17 cells were not significantly different between nSS and pSS patients. Only CD8 T cells were significantly increased in probable SS patients as compared to nSS patients (p<0.05). Percentages of CD3 and B cells positively correlated with CD3 and CD19 RNA expression (r=0.608, p<0.0001; r=0.598, p<0.0001, resp.). Interestingly, percentages of Tfh cells correlated with CXCL13 (r=0.789, p<0.0001), IL7R, CXCR5 and ICOS RNA expression (all p≤0.0001) and were strongly associated with autoimmunity (SSA positivity, p<0.001).

Conclusion: Epigenetic cell counting is a promising novel tool to reproducibly and easily quantify immune cells in the (inflamed) labial salivary gland of sicca patients with relatively low amount of tissue needed (<1 mm3). Considering the potential of this technique to include a huge number of (cell-specific) biomarkers we believe this opens up new standardized ways for salivary gland analysis with high relevance for patient classification, understanding of immunopathology and clinical trials.


Disclosure: J. A. G. van Roon, None; F. M. Moret, None; S. L. M. Blokland, None; A. A. Kruize, None; G. Bouma, None; A. van Maurik, None; S. Olek, None; U. Hoffmueller, None; T. R. D. J. Radstake, None.

To cite this abstract in AMA style:

van Roon JAG, Moret FM, Blokland SLM, Kruize AA, Bouma G, van Maurik A, Olek S, Hoffmueller U, Radstake TRDJ. Epigenetic Cell Counting: A Novel Tool to Quantify Immune Cells in Salivary Glands Detects Robust Correlations of T Follicular Helper Cells with Immunopathology [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/epigenetic-cell-counting-a-novel-tool-to-quantify-immune-cells-in-salivary-glands-detects-robust-correlations-of-t-follicular-helper-cells-with-immunopathology/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epigenetic-cell-counting-a-novel-tool-to-quantify-immune-cells-in-salivary-glands-detects-robust-correlations-of-t-follicular-helper-cells-with-immunopathology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology